Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Primary tabs

AMAG Pharmaceuticals appoints chief compliance officer

Scuttlebutt | September 29, 2017

AMAG Pharmaceuticals has appionted Tracy Palmer Berns as chief compliance officer, effective immediately. She will report to Joseph Vittiglio, general counsel and senior vice president of legal affairs and quality.

In her role at AMAG, Berns will be responsible for the company's compliance program and therapeutic-product legal team and provide legal advice on regulatory, development, pharmacovigilance and quality matters. Additionally, she will further strengthen the organization's culture to continue to prioritize ethics and compliance.

Berns brings more than 20 years of healthcare industry experience, creating effective compliance programs focused on policies, training, risk assessment, monitoring, investigations and discipline. Most recently, she served as the vice president of ethics and compliance within the Minimally Invasive Therapies Group at Medtronic, reporting to the president of the division and Medtronic's chief ethics and compliance officer.


Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.